NSE · NEOCHEM
Neochem Bio Solutions Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹86 Cr with net profit ₹8 Cr — a 9% net margin, versus 2.9% the period before.
Shareholding
As of 2026-03-31
- Promoter66.72%
- Public17.28%
- FII0.18%
- DII15.82%
406 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.92× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #1 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,66,203 Cr | 286.99 | 15.34 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,552 Cr | 298.65 | 26.06 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,434 Cr | 134.79 | 5.59 | 13.07% | 11.9% |
| Linde India Limited | ₹57,119 Cr | 737.61 | 13.39 | 12.48% | 0.18% |
| Gujarat Fluorochemicals Ltd. | ₹50,111 Cr | 459.86 | 6.42 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,596 Cr | 98.13 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,803 Cr | 182.32 | 9.75 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,633 Cr | 192.39 | 8.21 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,924 Cr | 104.33 | 3.93 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,733 Cr | 148.77 | 3.03 | 10.77% | 6.41% |
| Neochem Bio Solutions Ltd.(this company) | — | 0 | 2.2 | 15.25% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashNeochem Bio Solutions Ltd. (NEOCHEM) operates in the Chemicals sector. As of March 31, 2026, promoter shareholding stood at 66.72% while public shareholding was 17.28%. The company reported a Return on Equity (ROE) of 15.25% and a Return on Capital Employed (ROCE) of 27.19%.
Positives
- +Revenue increased by 38.95% from Rs 62.01 Cr in March 2024 to Rs 86.15 Cr in March 2025.
- +Net profit increased by 330.56% from Rs 1.80 Cr in March 2024 to Rs 7.75 Cr in March 2025.
- +Return on Capital Employed (ROCE) is 27.19%.
Negatives
- −The debt-to-equity ratio is high at 2.17.
- −Earnings per share (EPS) in March 2024 (Rs 1.90) was lower than in March 2023 (Rs 2.10).
- −Quarterly results have not been disclosed.
Financial Performance
Neochem Bio Solutions Ltd. recorded revenue of Rs 86.15 Cr in March 2025, an increase from Rs 62.01 Cr in March 2024. Net profit also increased to Rs 7.75 Cr in March 2025 from Rs 1.80 Cr in March 2024. Earnings per share (EPS) grew to Rs 6.64 in March 2025 from Rs 1.90 in March 2024.
Profitability & Returns
The company reported a Return on Equity (ROE) of 15.25%. Return on Capital Employed (ROCE) was 27.19%. The company's EPS was Rs 6.64 in March 2025, an increase from Rs 1.90 in March 2024 and Rs 2.10 in March 2023.
Balance Sheet
The debt-to-equity ratio for Neochem Bio Solutions Ltd. is 2.17. The book value per share is Rs 41.89. No further details on the balance sheet are available in the provided data.
Ownership & Pledges
As of March 31, 2026, promoters held 66.72% of the company's shares. Public shareholding was 17.28%, while institutions held 15.99%. Foreign Institutional Investors (FIIs) held 0.18% of the shares. There were no promoter pledges reported as of March 31, 2026.
Regulatory & Surveillance
Neochem Bio Solutions Ltd. is currently under ESM (Enhanced Surveillance Measure) Stage 1. This includes measures such as a 100% margin on all trades and a trading frequency of weekly settlement, as indicated by the 'ESM' label.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Neochem Bio Solutions Ltd.share price & fundamentals